How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
31
REGN Quote, Financials, Valuation and Earnings
Last price:
$633.98
Seasonality move
:
3.82%
Day range:
$631.45 - $642.97
52-week range:
$629.02 - $1,211.20
Dividend yield:
0.14%
P/E ratio:
16.65x
P/S ratio:
5.16x
P/B ratio:
2.37x
Volume:
805.9K
Avg. volume:
918.3K
1-year change:
-33.78%
Market cap:
$69.7B
Revenue:
$14.2B
EPS (TTM):
$38.28
Earnings Data
Next earnings date for REGN
Apr 29
2025
Most recent earnings per share
$8.06
Missed by $3.13
(Feb 4/2025)
Consensus Estimate
$11.19
(Feb 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
REGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $3.6B | -- | -- | $10.38 | -- |
| 04/29/2025 | Q1 | $3.4B | -- | -- | $9.26 | -- |
| 02/04/2025 | Q4 | $3.7B | $3.8B | $8.06 | $11.19 | -$3.13 |
| 10/31/2024 | Q3 | $3.7B | $3.7B | $11.54 | $11.70 | -$0.16 |
| 08/01/2024 | Q2 | $3.4B | $3.5B | $12.41 | $10.62 | $1.79 |
| 05/02/2024 | Q1 | $3.2B | $3.1B | $6.27 | $10.10 | -$3.83 |
| 02/02/2024 | Q4 | $3.3B | $3.4B | $10.19 | $10.75 | -$0.56 |
| 11/02/2023 | Q3 | -- | -- | $8.89 | $10.78 | -$1.89 |
| 08/03/2023 | Q2 | -- | -- | $8.50 | $9.90 | -$1.40 |
| 05/04/2023 | Q1 | -- | -- | $7.17 | $9.56 | -$2.39 |
| 02/03/2023 | Q4 | -- | -- | $10.50 | $10.01 | $0.49 |
| 11/03/2022 | Q3 | -- | -- | $11.66 | $9.48 | $2.18 |
| 08/03/2022 | Q2 | -- | -- | $7.47 | $8.76 | -$1.29 |
| 05/04/2022 | Q1 | -- | -- | $8.61 | $9.80 | -$1.19 |
| 02/04/2022 | Q4 | -- | -- | $19.69 | $20.30 | -$0.61 |
| 11/04/2021 | Q3 | -- | -- | $14.33 | $9.94 | $4.39 |
| 08/05/2021 | Q2 | -- | -- | $27.97 | $17.71 | $10.26 |
| 05/06/2021 | Q1 | -- | -- | $10.09 | $8.68 | $1.41 |
| 02/05/2021 | Q4 | -- | -- | $10.24 | $8.29 | $1.95 |
| 11/05/2020 | Q3 | -- | -- | $7.39 | $6.99 | $0.40 |
| 08/05/2020 | Q2 | -- | -- | $7.61 | $5.97 | $1.64 |
| 05/05/2020 | Q1 | -- | -- | $5.43 | $6.09 | -$0.66 |
| 02/06/2020 | Q4 | -- | -- | $6.93 | $7.17 | -$0.24 |
| 11/05/2019 | Q3 | -- | -- | $5.86 | $6.40 | -$0.54 |
| 08/06/2019 | Q2 | -- | -- | $6.02 | $5.42 | $0.60 |
| 05/07/2019 | Q1 | -- | -- | $4.45 | $5.52 | -$1.07 |
| 02/06/2019 | Q4 | -- | -- | $6.84 | $5.60 | $1.24 |
| 11/06/2018 | Q3 | -- | -- | $5.87 | $5.06 | $0.81 |
| 08/02/2018 | Q2 | -- | -- | $5.45 | $4.68 | $0.77 |
| 05/03/2018 | Q1 | -- | -- | $4.67 | $4.34 | $0.33 |
| 02/08/2018 | Q4 | -- | -- | $5.23 | $4.57 | $0.66 |
| 11/08/2017 | Q3 | -- | -- | $3.99 | $3.82 | $0.17 |
| 08/03/2017 | Q2 | -- | -- | $4.17 | $3.18 | $0.99 |
| 05/04/2017 | Q1 | -- | -- | $2.92 | $3.07 | -$0.15 |
| 02/09/2017 | Q4 | -- | -- | $3.04 | $3.05 | -$0.01 |
| 11/04/2016 | Q3 | -- | -- | $2.41 | $2.27 | $0.14 |
| 08/04/2016 | Q2 | -- | -- | $2.11 | $1.73 | $0.38 |
| 05/05/2016 | Q1 | -- | -- | $1.45 | $1.24 | $0.21 |
| 02/09/2016 | Q4 | -- | -- | $1.46 | $2.69 | -$1.23 |
| 11/04/2015 | Q3 | -- | -- | $2.59 | $2.62 | -$0.03 |
| 08/04/2015 | Q2 | -- | -- | $2.36 | $1.81 | $0.55 |
Regeneron Pharmaceuticals Earnings Questions
-
How Much did Regeneron Pharmaceuticals Generate in Revenue Last Quarter?
Regeneron Pharmaceuticals reported $3.8B worth of top line sales in its most recent quarter.
-
Did Regeneron Pharmaceuticals Beat Earnings Last Quarter?
Regeneron Pharmaceuticals announced earnings per share of $8.06 which represents a miss of analyst forecast a $11.19 per share.
-
Is Regeneron Pharmaceuticals Profitable?
Regeneron Pharmaceuticals reported $3.2B that represents $28.38 per share over the last quarter.
-
What is the Analyst Consensus for Regeneron Pharmaceuticals EPS Next Year?
Regeneron Pharmaceuticals's earnings are forecast to grow from $38.34 per share to $44.92 per share next year representing an increase of 13.66%.
-
When is Regeneron Pharmaceuticals's Earnings Date?
Regeneron Pharmaceuticals's next earnings date is April 29, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
